Table 1 Cell viability
| Â | CAL27 | SCC15 | SCC25 | HGF-1 |
|---|---|---|---|---|
| Â | 73% | 79% | 80% | 84% |
HPV16 | 94% | 80% | 86% | 94% |
HPV18 | 95% | 88% | 79% | 93% |
FA [100 μg/mL] | 96% | 94% | 97% | 91% |
FA [400 μg/mL] | 96% | 91% | 99% | 93% |
| Â | CAL27 | SCC15 | SCC25 | HGF-1 |
|---|---|---|---|---|
| Â | 73% | 79% | 80% | 84% |
HPV16 | 94% | 80% | 86% | 94% |
HPV18 | 95% | 88% | 79% | 93% |
FA [100 μg/mL] | 96% | 94% | 97% | 91% |
FA [400 μg/mL] | 96% | 91% | 99% | 93% |